Structural-Based Optimizations of the Marine-Originated Meridianin C as Glucose Uptake Agents by Inhibiting GSK-3β
Glycogen synthase kinase 3β (GSK-3β) is a widely investigated molecular target for numerous diseases, and inhibition of GSK-3β activity has become an attractive approach for the treatment of diabetes. Meridianin C, an indole-based natural product isolated from marine <i>Aplidium meridianum<...
Main Authors: | Shuwen Han, Chunlin Zhuang, Wei Zhou, Fener Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/19/3/149 |
Similar Items
-
Anti-inflammatory and anticancer effects of flavonol glycosides from Diplotaxis harra through GSK3β regulation in intestinal cells
by: Imen Nasri, et al.
Published: (2017-01-01) -
The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells
by: Ata ur Rahman Mohammed Abdul, et al.
Published: (2018-01-01) -
GSK-3β and Vitamin D Receptor are Involved in β-Catenin and Snail Signaling in High Glucose-Induced Epithelial-Mesenchymal Transition of Mouse Podocytes
by: Jia Guo, et al.
Published: (2014-04-01) -
GSK3β and the aging kidney
by: Kreidberg, J.A, et al.
Published: (2022) -
Glycogen Synthase Kinase 3β Modulates the Inflammatory Response Activated by Bacteria, Viruses, and Parasites
by: Ricarda Cortés-Vieyra, et al.
Published: (2021-05-01)